Industry

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pipeline Expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category1 GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping … [Read more…]

Welcoming Tracy Funk to the BST Team

With her expertise in benefit administration communication, Tracy Funk will heighten Benefits Science Technologies’ partnership trajectory with premium insights and innovative thoughts on the industry. BOSTON–(BUSINESS WIRE)–Benefits Science Technologies (BST) is proud to announce that Tracy Funk will be our new Supplemental Benefits and Benefit Administration Practice Lead. Her responsibilities will inspire customer satisfaction while … [Read more…]

BitNile Holdings Reports Third Quarter 2022 Financial Results, Including Revenue of $100 Million for the Nine Months Ended September 30, 2022, up 124% from the Prior Year’s Nine-Month Period

LAS VEGAS–(BUSINESS WIRE)–$ALZN #100_million_gross_revenue—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), reported its financial results for the third quarter ended September 30, 2022 on its Form 10-Q filed with the Securities and Exchange Commission. Third quarter 2022 highlights include: Total assets of $610.9 million as of September 30, 2022; … [Read more…]

Chip and Joanna Gaines, Luis Fonsi, Michael Strahan, Sofia Vergara and celebrities and influencers to rally communities everywhere this Giving Tuesday and holiday season for St. Jude Children’s Research Hospital

Social media takeovers, immersive experiences, pop-up store, livestreams connect donors to mission of St. Jude on November 29 MEMPHIS, Tenn.–(BUSINESS WIRE)–Millions of supporters are joining celebrities and influencers across music, sports, and entertainment including Gaby Espino (@gabyespino), Barry Brandon (@thequeerindigo), Sasha Pieterse (@sashapieterse), and Vivian Tu (@yourrichbff) who are taking to their social channels on … [Read more…]

Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference at 2:00 pm ET on Wednesday, November 30, … [Read more…]

Gamida Cell Provides Regulatory Update on Omidubicel

Recent company submission in response to FDA request extends PDUFA date by three months BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematological and solid cancers and other serious diseases, today provided an update on recent interactions with the U.S. Food and Drug Administration (FDA) … [Read more…]

Amber Specialty Pharmacy Selected to Dispense TZIELD™ (teplizumab), a Monoclonal Antibody Treatment to Delay Onset of Stage 3 Type 1 Diabetes in Patients Ages 8 Years and Older with Stage 2 Type 1 Diabetes

OMAHA, Neb.–(BUSINESS WIRE)–Amber Specialty Pharmacy announces that it will begin dispensing TZIELD™ (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D. Indication for individuals ages 8 years and older with Stage 2 T1D is categorized by the presence of two … [Read more…]

Afya Limited Announces Third-Quarter and Nine Months 2022 Financial Results

Guidance On Track Robust EPS Expansion NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2022 (third quarter 2022). Financial results are expressed in Brazilian Reais … [Read more…]

Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat

IRVINE, Calif.–(BUSINESS WIRE)–#TreatmentCenter–Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company’s Chief Investment Officer; Peter Nyland, the company’s Executive Vice President of Asset Management; Darrin Smith, the company’s Executive Vice President of Investments; and Eliza Gozar, the company’s Senior Vice President of Investments, will attend the eighth annual Treatment Center … [Read more…]

Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the closing of its underwritten public offering of 35,075,000 shares of its common stock at a price to the public of $1.15 per share, including the exercise in full by the underwriter of its … [Read more…]